Routine dexamethasone is not effective compared to placebo to treat dyspnea in patients with advanced cancer
1. There is no significant difference for perceived dyspnea in patients taking dexamethasone as compared to placebo. 2. Cancer patients ...
Tag: dexamethasone
![ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
The RECOVERY trial: Dexamethasone decreased mortality in hospitalized COVID-19 patients [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
High dose dexamethasone does not improve survival in patients with hypoxemic respiratory failure due to COVID-19
1. High dose dexamethasone was nonsuperior in regards to 60-day survival outcomes as compared with regular dose dexamethasone in COVID-19 ...
Daily 12 mg dexamethasone not superior to 6 mg for severe COVID-19 infection
1. This multi-centered, randomized controlled trial demonstrated that 12 mg and 6 mg dexamethasone daily had similar efficacy for days ...
Inhaled budesonide shortens time to recovery for high-risk COVID-19 patients in the community
1. Time to recovery was lower in patients assigned to budesonide compared to usual care, meeting the superiority criteria. 2. ...
Daratumumab therapy addition improved response in systemic immunoglobulin light-chain amyloidosis
1. Daratumumab therapy addition to bortezomib, cyclophosphamide, and dexamethasone showed improved cancer response in patients with systemic immunoglobulin light-chain amyloidosis. ...
